Change in body temperature, not acute-phase reaction, predict anti-Osteoporosis efficacy after the first administration of Zoledronic acid: a prospective observational cohort study

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
Extent
1 Online-Ressource.
Language
Englisch

Bibliographic citation
Change in body temperature, not acute-phase reaction, predict anti-Osteoporosis efficacy after the first administration of Zoledronic acid: a prospective observational cohort study ; volume:25 ; number:1 ; day:2 ; month:9 ; year:2024 ; pages:1-12 ; date:12.2024
BMC musculoskeletal disorders ; 25, Heft 1 (2.9.2024), 1-12, 12.2024

Creator
Du, Yanping
Yu, Weijia
Gou, Haixin
Lei, Yiming
Zhang, Tongkai
Tang, Wenjing
Chen, Minmin
Li, Huilin
Cheng, Qun
Contributor
SpringerLink (Online service)

DOI
10.1186/s12891-024-07781-8
URN
urn:nbn:de:101:1-2411180025297.397643748685
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
15.08.2025, 7:33 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Du, Yanping
  • Yu, Weijia
  • Gou, Haixin
  • Lei, Yiming
  • Zhang, Tongkai
  • Tang, Wenjing
  • Chen, Minmin
  • Li, Huilin
  • Cheng, Qun
  • SpringerLink (Online service)

Other Objects (12)

Hepatotoxicity induced by zoledronic acid in an aged woman with primary osteoporosis

Hepatotoxicity induced by zoledronic acid in an aged woman with primary osteoporosis

Zoledronic acid ameliorates the effects of secondary osteoporosis in rheumatoid arthritis patients

Zoledronic acid ameliorates the effects of secondary osteoporosis in rheumatoid arthritis patients

Adherence to and persistence with zoledronic acid treatment for osteoporosis—reasons for early discontinuation

Adherence to and persistence with zoledronic acid treatment for osteoporosis—reasons for early discontinuation

Effect of zoledronic acid on muscle metabolism in mice with osteoporosis combined with sarcopenia

Effect of zoledronic acid on muscle metabolism in mice with osteoporosis combined with sarcopenia

Administration of zoledronic acid alleviates osteoporosis in HIV patients by suppressing osteoclastogenesis via regulating RANKL expression

Administration of zoledronic acid alleviates osteoporosis in HIV patients by suppressing osteoclastogenesis via regulating RANKL expression

Cost-effectiveness analysis of once-yearly injection of zoledronic acid for the treatment of osteoporosis in Japan

Cost-effectiveness analysis of once-yearly injection of zoledronic acid for the treatment of osteoporosis in Japan

The effectiveness of intravenous zoledronic acid in elderly patients with osteoporosis after rotator cuff repair: a retrospective study

The effectiveness of intravenous zoledronic acid in elderly patients with osteoporosis after rotator cuff repair: a retrospective study

Preventing OsteoPorosis in Spinal Cord Injury (POPSCI) Study—Early Zoledronic Acid Infusion in Patients with Acute Spinal Cord Injury

Preventing OsteoPorosis in Spinal Cord Injury (POPSCI) Study—Early Zoledronic Acid Infusion in Patients with Acute Spinal Cord Injury

Traditional risk factors do not predict osteoporosis in HIV patients

Traditional risk factors do not predict osteoporosis in HIV patients

Combining OSTA and BMR to predict osteoporosis in Chinese population

Combining OSTA and BMR to predict osteoporosis in Chinese population

Mandibular Bone Mineral Density to predict Skeletal Osteoporosis: A Literature Review

Mandibular Bone Mineral Density to predict Skeletal Osteoporosis: A Literature Review

Effects of once-yearly zoledronic acid on bone density and incident vertebral fractures in nonmetastatic castration-sensitive prostate cancer patients with osteoporosis

Effects of once-yearly zoledronic acid on bone density and incident vertebral fractures in nonmetastatic castration-sensitive prostate cancer patients with osteoporosis

Related objects